{"id":"W2581871698","doi":"10.1182/blood.v108.11.4665.4665","title":"Fludarabine and Mitoxantrone for the Refractory Relapse Treatment of B-Cell Low-Grade Non-Hodgkin Lymphoma (NHL): LACOHG First Interim Report (Latin American Cooperative Oncology Hematology Group).","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mitoxantrone; Internal medicine; Fludarabine; International Prognostic Index; Oncology; Follicular lymphoma; Hematology; Transplantation; Performance status; Cyclophosphamide; Rituximab; Surgery; Lymphoma; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001466266,0.0002460015,0.00037282,0.0002471063,0.0002013638,0.0002870155,0.0003571827,0.0004209173,0.002053345],"category_scores_gemma":[0.0005940257,0.00008825384,0.0003256252,0.0002382737,0.0001568815,0.0001711397,0.0002108459,0.0003501811,0.0003766853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005090621,"about_ca_system_score_gemma":0.001078598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001076001,"about_ca_topic_score_gemma":0.002136809,"domain_scores_codex":[0.9997067,0.0001508209,0.00003296148,0.00001691327,0.00003550324,0.00005700862],"domain_scores_gemma":[0.9996454,0.00007854615,0.00008431917,0.00001972582,0.00005355667,0.00011851],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0371562,0.003509867,0.2790515,0.002189978,0.0008652027,0.002865162,0.0003582614,0.0005382388,0.02412805,0.0003912143,0.02996018,0.6189863],"study_design_scores_gemma":[0.02483433,0.04766978,0.7301352,0.0005649342,0.001325418,0.005742413,0.0002844706,0.0007673099,0.01034732,0.0002613577,0.1780298,0.00003768578],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9126499,0.06760722,0.0008221383,0.004284724,0.0005009192,0.001498209,0.002151099,0.00009817483,0.0103877],"genre_scores_gemma":[0.9752207,0.01041215,0.001382985,0.00288768,0.0008160541,0.000774342,0.004303482,0.00001536184,0.004187185],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002053345,"threshold_uncertainty_score":0.007754385,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01241674892237238,"score_gpt":0.2753732552975033,"score_spread":0.2629565063751309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}